NYSE:CNMDMedical Equipment
Reassessing CONMED (CNMD) Valuation After Soft Demand Trends And CFO Transition News
CONMED (CNMD) has held its full year 2025 earnings and revenue guidance steady while announcing the planned departure of long serving CFO Todd Garner. This combination has drawn fresh attention to the stock.
See our latest analysis for CONMED.
The reaffirmed 2025 guidance and upcoming CFO transition come after a mixed period, with a 1 day share price return of 3.87% to US$41.58 but a 1 year total shareholder return decline of 38.19%. This suggests momentum has softened even as recent news has...